BioRestorative Therapies, Inc.— Sankey Diagram
Annual mode · period ending 2025-12-31 · SEC EDGAR
FY2025 - Q4(Oct 25 · Nov 25 · Dec 25)
Total Assets
$4M
↓-66.8% -$8Mvs FY2024
Total Liabilities
$4M
↓-0.7% -$26Kvs FY2024
Equity
$357K
↓-95.8% -$8Mvs FY2024
Cash
$2M
↑+175.8% +$963Kvs FY2024
Click a Metric or Sankey Node to View Historical Trends
Show Source Data (Audit Panel)
| Line item | FY2025 | FY2024 |
|---|---|---|
| Total Assets | $4M | $12M |
| Current Assets | $3M | $11M |
| Cash | $2M | $548K |
| ST Investments | $1M | $10M |
| Receivables | $16K | $188K |
| Inventory | $0 | $0 |
| Other Current | $168K | $223K |
| Non-Current Assets | $943K | $1M |
| PPE | $359K | $363K |
| Goodwill | $0 | $0 |
| Intangibles | $534K | $624K |
| Investments | $0 | $0 |
| Other Non-Current | $50K | $149K |
| Total Liab+Eq | $357K | $12M |
| Current Liab. | $4M | $4M |
| Accounts Payable | $1M | $483K |
| Short-Term Debt | $0 | $0 |
| Deferred Revenue | $0 | $0 |
| Other CL | $2M | $3M |
| Non-Current Liab. | $0 | $0 |
| Long-Term Debt | $0 | $0 |
| Other LT Liab. | $0 | $0 |
| Equity | $357K | $9M |
| Retained Earnings | $170M | $156M |
| Other Equity | $0 | $0 |
QuarterCharts · SEC EDGAR data · BRTX · Comparing FY2025 vs FY2024